Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease
A varying response to cholinesterase inhibitor (ChEI) treatment has been reported among patients with Alzheimer's disease (AD). Whether the individual-specific response, specific ChEI agent or dose affects mor...